US Patent 10624864 Epinephrine formulations
Patent 10624864 was granted and assigned to Par Pharmaceutical on April, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10624864 Epinephrine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
